GIP receptors fire in the gut, the pancreas, and deep in the hypothalamus
These devices are not suitable for maintaining 2C to 8C
Diabetes Care 43(1):3743 Bergenstal RM, Garg S, Weinzimer SA, Buckingham BA, Bode BW, Tamborlane WV et al (2016) Safety of a hybrid closed-loop insulin delivery system in patients with type 1 diabetes
Retatrutide Trials - The Nitty Gritty Pre-Clinical Trials Coskun et al
Here's where people often get tripped up: Works well: A turkey wrap with a thin smear of hummus
Heavy or Dependent Drinking If alcohol consumption exceeds 14+ drinks per week, or if stopping creates withdrawal symptoms: Medical supervision is essential: Combining retatrutide with heavy alcohol use requires close monitoring Address alcohol use first: Consider addiction medicine consultation before optimizing weight loss medication GLP-1 agonists may reduce alcohol cravings: Emerging research suggests these medications decrease alcohol seeking behavior in some people Liver damage risk is significant: The combination creates substantial hepatotoxic potential Consider treatment programs: Resources like CAMH (Centre for Addiction and Mental Health) offer evidence-based approaches Interestingly, some research suggests GLP-1 receptor agonists may actually help reduce alcohol consumption in people with alcohol use disorder, though this remains an area of active investigation rather than established clinical practice
